Successful treatment of intravascular papillary endothelial hyperplasia (IPEH) by the beta-adrenergic antagonist nebivolol

Br J Dermatol. 2012 May;166(5):1147-9. doi: 10.1111/j.1365-2133.2011.10755.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / therapeutic use*
  • Adult
  • Benzopyrans / therapeutic use*
  • Endothelium, Vascular / pathology*
  • Ethanolamines / therapeutic use*
  • Fingers
  • Humans
  • Hyperplasia / drug therapy
  • Male
  • Nebivolol
  • Treatment Outcome
  • Vascular Neoplasms / drug therapy*

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Benzopyrans
  • Ethanolamines
  • Nebivolol